Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 17;72(46):1250-1256.
doi: 10.15585/mmwr.mm7246a1.

Trends in the Prevalence of Chronic Obstructive Pulmonary Disease Among Adults Aged ≥18 Years - United States, 2011-2021

Trends in the Prevalence of Chronic Obstructive Pulmonary Disease Among Adults Aged ≥18 Years - United States, 2011-2021

Yong Liu et al. MMWR Morb Mortal Wkly Rep. .

Abstract

Chronic obstructive pulmonary disease (COPD) is a leading cause of death in the United States. Overall COPD prevalence declined during 1999-2011. Trends in COPD prevalence during the previous decade have not been reported. CDC analyzed 2011-2021 Behavioral Risk Factor Surveillance System data to assess trends and differences in self-reported physician-diagnosed COPD prevalence among U.S. adults aged ≥18 years. Age-standardized prevalence of COPD did not change significantly from 2011 (6.1%) to 2021 (6.0%). Prevalence was stable for most states and subgroups; however, it decreased significantly among adults aged 18-44 years (average annual percent change [AAPC] = -2.0%) and increased significantly among those aged ≥75 years (AAPC = 1.3%), those living in micropolitan counties (0.8%), and among current (1.5%) or former (1.2%) smokers. COPD prevalence remained elevated in the following groups: women, adults aged ≥65 years, those with a lower education level, unable to work, living in rural areas, and who ever smoked. Evidence-based strategies, especially those tailored for adults disproportionately affected, can reduce COPD prevalence, and address the continued need for prevention, early diagnosis, treatment, and management.

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Figures

FIGURE
FIGURE
Prevalence* of chronic obstructive pulmonary disease among adults aged ≥18 years, by selected characteristics — Behavioral Risk Factor Surveillance System, United States, 2011–2021 Abbreviation: GED = general educational development certificate. *Estimates were calculated using sampling weights and estimates by education level, urban-rural status, and smoking status were age-standardized using the 2000 Census Bureau projected U.S. adult population with five age groups (18–24, 25–34, 35–44, 45–64, and ≥65 years) Distribution #9. https://www.cdc.gov/nchs/data/statnt/statnt20.pdf

References

    1. Xu J, Murphy SL, Kochanek KD, Arias E. Mortality in the United States, 2021. NCHS data brief, no. 456. Atlanta, GA: National Center for Health Statistics; 2022. https://www.cdc.gov/nchs/data/databriefs/db456.pdf - PubMed
    1. Wheaton AG, Liu Y, Croft JB, et al. Chronic obstructive pulmonary disease and smoking status–—United States, 2017. MMWR Morb Mortal Wkly Rep 2019;68:533–8. 10.15585/mmwr.mm6824a1 - DOI - PMC - PubMed
    1. Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD surveillance—United States, 1999–2011. Chest 2013;144:284–305. 10.1378/chest.13-0809 - DOI - PMC - PubMed
    1. Carlson SA, Wheaton AG, Watson KB, Liu Y, Croft JB, Greenlund KJ. Geographic differences in sex-specific chronic obstructive pulmonary disease mortality rate trends among adults aged ≥25 years—United States, 1999–2019. MMWR Morb Mortal Wkly Rep 2022;71:613–8. 10.15585/mmwr.mm7118a1 - DOI - PMC - PubMed
    1. Jamal A, King BA, Neff LJ, Whitmill J, Babb SD, Graffunder CM. Current cigarette smoking among adults—United States, 2005–2015. MMWR Morb Mortal Wkly Rep 2016;65:1205–11. 10.15585/mmwr.mm6544a2 - DOI - PubMed